ADAM12 and breast cancer: Following silencing of ADAM12 expression, SKBR3 and MDA-MB-231 cells became significantly sensitive to 5-FU and slightly sensitive to cDDP, suggesting that ADAM12-L might play a role in the resistance of breast cancer cells to 5-FU.